102 related articles for article (PubMed ID: 15878699)
1. NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2.
Smialowski P; Singh M; Mikolajka A; Majumdar S; Joy JK; Nalabothula N; Krajewski M; Degenkolbe R; Bernard HU; Holak TA
Biochim Biophys Acta; 2005 Jun; 1750(1):48-60. PubMed ID: 15878699
[TBL] [Abstract][Full Text] [Related]
2. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation.
Zhang JM; Zhao X; Wei Q; Paterson BM
EMBO J; 1999 Dec; 18(24):6983-93. PubMed ID: 10601020
[TBL] [Abstract][Full Text] [Related]
4. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.
Iavarone A; Garg P; Lasorella A; Hsu J; Israel MA
Genes Dev; 1994 Jun; 8(11):1270-84. PubMed ID: 7926730
[TBL] [Abstract][Full Text] [Related]
5. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
[TBL] [Abstract][Full Text] [Related]
6. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
7. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation.
Novitch BG; Spicer DB; Kim PS; Cheung WL; Lassar AB
Curr Biol; 1999 May; 9(9):449-59. PubMed ID: 10322110
[TBL] [Abstract][Full Text] [Related]
8. Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
Nguyen DX; Baglia LA; Huang SM; Baker CM; McCance DJ
EMBO J; 2004 Apr; 23(7):1609-18. PubMed ID: 15044952
[TBL] [Abstract][Full Text] [Related]
9. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD.
Lemercier C; To RQ; Carrasco RA; Konieczny SF
EMBO J; 1998 Mar; 17(5):1412-22. PubMed ID: 9482738
[TBL] [Abstract][Full Text] [Related]
10. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
11. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation.
Sekiguchi T; Nishimoto T; Hunter T
Oncogene; 1999 Mar; 18(10):1797-806. PubMed ID: 10086334
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
15. Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis.
Puri PL; Iezzi S; Stiegler P; Chen TT; Schiltz RL; Muscat GE; Giordano A; Kedes L; Wang JY; Sartorelli V
Mol Cell; 2001 Oct; 8(4):885-97. PubMed ID: 11684023
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
17. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
18. A two-hybrid system for transactivator bait proteins.
Hirst M; Ho C; Sabourin L; Rudnicki M; Penn L; Sadowski I
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8726-31. PubMed ID: 11447261
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
[TBL] [Abstract][Full Text] [Related]
20. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
